Brussels, Belgium

Georges Mairet-Coello

This inventor holds 7 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Ucb Biopharma Sprl, Ucbbiopharma Srl. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Georges Mairet-Coello. Retrieved from https://idiyas.com/inventor/georges-mairet-coello

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 85.7

 

Average Co-Inventor Count = 6.5

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2019-2026

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Georges Mairet-Coello: A Pioneering Inventor from Brussels

Introduction: Georges Mairet-Coello, based in Brussels, Belgium, is a distinguished inventor known for his contributions to the field of biotechnology. With a total of six patents to his name, his work primarily revolves around the development of Tau-binding antibodies, which have significant implications in the medical field, particularly regarding neurodegenerative diseases.

Latest Patents: Among Georges Mairet-Coello's most notable recent inventions are his patents related to Tau-binding antibodies. These patents detail innovative methods for creating antibodies and their binding fragments, which are essential for therapeutic applications in combating conditions associated with tau protein dysfunction.

Career Highlights: Throughout his career, Mairet-Coello has worked with UCB Biopharma, a leading biopharmaceutical company, where he has likely played a crucial role in advancing research and development in the field. His experience in such a reputable organization highlights his expertise and dedication to his work.

Collaborations: Georges Mairet-Coello has collaborated with several esteemed professionals, including David Edward Ormonde Knight and Terence Seward Baker. These collaborations have likely fostered a rich exchange of ideas and innovations, contributing to the successful development of his patents.

Conclusion: In conclusion, Georges Mairet-Coello’s work exemplifies the spirit of innovation in the biotechnology sector. His patents on Tau-binding antibodies reflect a significant stride toward understanding and potentially treating complex neurodegenerative diseases. As he continues to contribute to the field, his work serves as an inspiration for future inventors and researchers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…